| Stage | TXRH | % of rev | MCD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.7B | 100.00% | $7.1B | 100.00% | MCD ×4.23 |
| Gross profit | $307M | 18.30% | $4.3B | 60.30% | MCD +42.0pp |
| Operating income | $143M | 8.50% | $3.3B | 47.02% | MCD +38.5pp |
| Pre-tax income | $144M | 8.57% | $2.9B | 41.36% | MCD +32.8pp |
| Net income | $125M | 7.41% | $2.4B | 33.27% | MCD +25.9pp |
| Stage | TXRH | MCD | Gap · A − B |
|---|---|---|---|
| Revenue | $1.7B100.00% | $7.1B100.00% | MCD ×4.23 |
| Gross profit | 18.30%$307M | 60.30%$4.3B | MCD +42.0pp |
| Operating income | 8.50%$143M | 47.02%$3.3B | MCD +38.5pp |
| Pre-tax income | 8.57%$144M | 41.36%$2.9B | MCD +32.8pp |
| Net income |
| 7.41%$125M |
| 33.27%$2.4B |
| MCD +25.9pp |